新医学
新醫學
신의학
NEW CHINESE MEDICINE
2014年
6期
378-381
,共4页
张曦%金欧%黄红月%侯成成%古洁若
張晞%金歐%黃紅月%侯成成%古潔若
장희%금구%황홍월%후성성%고길약
羟氯喹%干扰素-α%Toll样受体-9%系统性红斑狼疮
羥氯喹%榦擾素-α%Toll樣受體-9%繫統性紅斑狼瘡
간록규%간우소-α%Toll양수체-9%계통성홍반랑창
Hydroxychloroquine%Interferon-alpha%TLR-9%Systemic lupus erythematosus
目的:初步探讨羟氯喹对Toll样受体-9(TLR-9)介导的人外周血单个核细胞(PB-MC)中IFN-α表达水平的影响。方法提取健康志愿者的PBMC。分别将PBMC与0、0.375、0.75、1.5、3.0、6.0μg/ml TLR-9激动剂ODN 2216共同培养12 h,以及与1.5μg/ml ODN 2216共同培养0、6、12、24、48 h,从细胞水平模拟SLE高表达IFN-α。然后用1.5μg/ml ODN 2216与PBMC共同培养6 h,加入羟氯喹1.25μg/ml (实验组)及等量的培养基(阳性对照组),在未加入ODN 2216的PBMC内加入等量的培养基(空白对照组),继续培养12 h后用实时荧光定量PCR法检测并比较各组PBMC中IFN-αmRNA表达水平。结果 PBMC与1.5μg/ml ODN 2216共同培养6 h时,IFN-αmRNA表达水平最高(P<0.01)。阳性对照组PBMC中IFN-αmRNA表达水平明显高于空白对照组(P<0.01)。与阳性对照组相比,实验组PBMC中IFN-αmRNA表达水平明显降低(P<0.05)。结论羟氯喹可明显抑制经TLR-9介导的IFN-α高表达。
目的:初步探討羥氯喹對Toll樣受體-9(TLR-9)介導的人外週血單箇覈細胞(PB-MC)中IFN-α錶達水平的影響。方法提取健康誌願者的PBMC。分彆將PBMC與0、0.375、0.75、1.5、3.0、6.0μg/ml TLR-9激動劑ODN 2216共同培養12 h,以及與1.5μg/ml ODN 2216共同培養0、6、12、24、48 h,從細胞水平模擬SLE高錶達IFN-α。然後用1.5μg/ml ODN 2216與PBMC共同培養6 h,加入羥氯喹1.25μg/ml (實驗組)及等量的培養基(暘性對照組),在未加入ODN 2216的PBMC內加入等量的培養基(空白對照組),繼續培養12 h後用實時熒光定量PCR法檢測併比較各組PBMC中IFN-αmRNA錶達水平。結果 PBMC與1.5μg/ml ODN 2216共同培養6 h時,IFN-αmRNA錶達水平最高(P<0.01)。暘性對照組PBMC中IFN-αmRNA錶達水平明顯高于空白對照組(P<0.01)。與暘性對照組相比,實驗組PBMC中IFN-αmRNA錶達水平明顯降低(P<0.05)。結論羥氯喹可明顯抑製經TLR-9介導的IFN-α高錶達。
목적:초보탐토간록규대Toll양수체-9(TLR-9)개도적인외주혈단개핵세포(PB-MC)중IFN-α표체수평적영향。방법제취건강지원자적PBMC。분별장PBMC여0、0.375、0.75、1.5、3.0、6.0μg/ml TLR-9격동제ODN 2216공동배양12 h,이급여1.5μg/ml ODN 2216공동배양0、6、12、24、48 h,종세포수평모의SLE고표체IFN-α。연후용1.5μg/ml ODN 2216여PBMC공동배양6 h,가입간록규1.25μg/ml (실험조)급등량적배양기(양성대조조),재미가입ODN 2216적PBMC내가입등량적배양기(공백대조조),계속배양12 h후용실시형광정량PCR법검측병비교각조PBMC중IFN-αmRNA표체수평。결과 PBMC여1.5μg/ml ODN 2216공동배양6 h시,IFN-αmRNA표체수평최고(P<0.01)。양성대조조PBMC중IFN-αmRNA표체수평명현고우공백대조조(P<0.01)。여양성대조조상비,실험조PBMC중IFN-αmRNA표체수평명현강저(P<0.05)。결론간록규가명현억제경TLR-9개도적IFN-α고표체。
Objectives To preliminarily investigate the effect of hydroxychloroquine on interferon-α(IFN-α)expression mediated by Toll like receptor-9 (TLR-9 )in human peripheral blood mononuclear cells (PBMCs). Methods PBMCs were freshly isolated from healthy donors. PBMCs were cultured with 0, 0.375,0.75,1.5,3.0,6.0 μg/ml TLR-9 agonist (ODN2216)for 12 h,or with 1.25 μg/ml ODN2216 for 0,6,12,24,48 h to mimic high expression of IFN-αin patients with SLE at the cell level. Then PBMCs were cultured with 1.5 μg/ml ODN 2216 for 6 h,and then treated with 1.25 μg/ml hydroxychloroquine (experi-ment group)or the same volume of medium (positive control group),and cultured for 12 h. PBMCs without any treatment were used as control group. Afterward,the expressions of IFN-αamong three groups were detec-ted by real-time quantitative PCR. Results When PBMCs were treated with 1.5 μg/ml ODN 2216 for 6 h, IFN-αmRNA expression reached the highest level (P<0.01). The expression of IFN-αmRNA in PBMC in positive control group was significantly higher than that of the control group(P<0.01). Compared with the positive control group,the mRNA expression of IFN-αin experiment group was significantly lower (P<0.05).Conclusions High expression of IFN-αmediated by TLR-9 may be inhibited by Hydroxychloroquine.